NCT01746680View on ClinicalTrials.gov

Efficacy and Safety Study of Tacrobell to Treat Rheumatoid Arthritis

PHASE4CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Tacrolimus with Methotrexate

Tacrolimus 1 mg for 0\~week4, 2mg for week4\~week8, 3mg for week8\~week24 with MTX ≤20mg/week

Trial Locations (1)

Unknown

Kyung Hee University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY